Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Pacira Therapeutics, INC
Pacira Therapeutics, INC is a converted/closed company incorporated on 11 September 2015 with the registered office located in . Pacira Therapeutics, INC was registered 10 years ago.
Watch Company
Status
Converted/closed
Company No
FC032939
Overseas company
Age
10 years
Incorporated
11 September 2015
Size
Large
Turnover is over
£54M
Balance sheet is over
£27M
Confirmation
Exempt
FC companies are not required to submit this
Accounts
Not Submitted
Awaiting first accounts
Learn more about Pacira Therapeutics, INC
Contact
Update Details
Address
1209 Orange Street
City Of Wilmington
County Of Newxastle
Delaware 19801
Same address since
incorporation
Companies in
Telephone
+1(781)305-7777
Email
Unreported
Website
Flexiontherapeutics.com
See All Contacts
People
Officers
3
Shareholders
-
Controllers (PSC)
-
Stephen McCairns
Director • VP, UK Operations • British • Lives in UK • Born in May 1970
Anthony Molloy
Director • Chief Legal & Compliance Officer • American • Lives in United States • Born in Feb 1974
Lauren Bullaro Riker
Director • SVP, Finance • American • Lives in United States • Born in Jun 1978
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Pacira Limited
Lauren Bullaro Riker is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2015–2022)
Period Ended
31 Dec 2022
For period
31 Dec
⟶
31 Dec 2022
Traded for
12 months
Cash in Bank
£86.06M
Decreased by £346.55M (-80%)
Turnover
£551.03M
Increased by £150.96M (+38%)
Employees
Unreported
Same as previous period
Total Assets
£1.39B
Decreased by £143.96M (-9%)
Total Liabilities
-£748.82M
Decreased by £244.78M (-25%)
Net Assets
£640.43M
Increased by £100.82M (+19%)
Debt Ratio (%)
54%
Decreased by 10.9% (-17%)
See 10 Year Full Financials
Latest Activity
Group Accounts Submitted
2 Years 3 Months Ago on 10 Aug 2023
Group Accounts Submitted
3 Years Ago on 26 Sep 2022
Stephen Mccairns Appointed
3 Years Ago on 1 Jul 2022
Lauren Riker Appointed
3 Years Ago on 1 Jul 2022
Anthony Molloy Appointed
3 Years Ago on 29 Jun 2022
Lauren Riker Appointed
4 Years Ago on 19 Nov 2021
Michael Clayman Resigned
4 Years Ago on 19 Nov 2021
Anthony Molloy Appointed
4 Years Ago on 19 Nov 2021
Neil Bodick Resigned
4 Years Ago on 19 Nov 2021
Stephen Mccairns Appointed
4 Years Ago on 19 Nov 2021
Get Alerts
Get Credit Report
Discover Pacira Therapeutics, INC's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Submitted on 27 Sep 2023
Group of companies' accounts made up to 31 December 2022
Submitted on 10 Aug 2023
Group of companies' accounts made up to 31 December 2021
Submitted on 26 Sep 2022
Appointment of Lauren Riker as a director on 19 November 2021
Submitted on 8 Jul 2022
Appointment of Stephen Mccairns as a director on 19 November 2021
Submitted on 1 Jul 2022
Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 19/11/2021 daniel leblanc
Submitted on 1 Jul 2022
Appointment of Lauren Riker as a person authorised to represent UK establishment BR018022 on 19 November 2021.
Submitted on 1 Jul 2022
Termination of appointment of Neil Bodick as a director on 19 November 2021
Submitted on 1 Jul 2022
Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 19/11/2021 david arkowitz
Submitted on 1 Jul 2022
Appointment of Stephen Mccairns as a person authorised to represent UK establishment BR018022 on 19 November 2021.
Submitted on 1 Jul 2022
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs